Impact of TASK-1 in Human Pulmonary Artery Smooth Muscle Cells
Andrea Olschewski(Medical University of Graz), Horst Olschewski(Sigmund Freud Privatuniversität Wien), Werner Seeger(Justus-Liebig-Universität Gießen), Walter Klepetko(Medical University of Vienna), Rory E. Morty(Heidelberg University), Bastian Eul(Hals- Nasen- und Ohrenklinik Gießen), Jochen Wilhelm(Justus-Liebig-Universität Gießen), Michael E. Bräu(University of Minnesota), Bi Tang(First Affiliated Hospital of Bengbu Medical College), Yingji Li(University of Minnesota), Rainer M. Bohle(Saarland University), Jörg Hänze(Philipps University of Marburg), Ε. Kenneth Weir(University of Minnesota), Grażyna Kwapiszewska(Cardio-Pulmonary Institute)
Cited by 232
Related Papers
Clinical classification of pulmonary hypertension
|Journal of the American College of Cardiology|2004|1.9k
Inhaled Iloprost for Severe Pulmonary Hypertension
|New England Journal of Medicine|2002|1.8k
Pulmonary hypertension in chronic lung disease and hypoxia
|European Respiratory Journal|2018|777
Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial
|The Lancet|2002|771
Pulmonary Hypertension in Chronic Lung Diseases
|Journal of the American College of Cardiology|2013|683